1.
Takamatsu H, Matsuda T, Mizuno S, Takahashi T, Fuchida S- ichi, Hanamura I, Kataoka K, Tsukada N, Matsumoto M, Hangaishi A, Doki N, Uchida N, Sawa M, Maruyama Y, Kurahashi S, Nagafuji K, Harazaki Y, Kako S, Iida S, Ichinohe T, Kanda Y, Atsuta Y, Sunami K, Society for Transplantation and Cellular Therapy MMWG in the J. Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs. haematol [Internet]. 2023Dec.1 [cited 2024May25];108(12):3399-408. Available from: https://haematologica.org/article/view/haematol.2023.283202